|
GenScript corporation
cpass svnt kit ![]() Cpass Svnt Kit, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/cpass+svnt+kit/cpass+svnt+kit/pmc09046723-178-3-2 Average 90 stars, based on 1 article reviews
cpass svnt kit - by Bioz Stars,
2026-09
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
doi: 10.3389/fcimb.2022.822599
Figure Lengend Snippet: Analytical performance of each kit in discriminating SARS-CoV-2 infection.
Article Snippet: For the
Techniques: Infection
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
doi: 10.3389/fcimb.2022.822599
Figure Lengend Snippet: Analytical performance for representativeness of neutralizing activity using the pre-defined cut-off values of each immunoassay kit.
Article Snippet: For the
Techniques: Activity Assay
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
doi: 10.3389/fcimb.2022.822599
Figure Lengend Snippet: Titer correlation of the analytical performance of the prediction of neutralizing activity using newly calculated cut-off values determined using Youden’s index.
Article Snippet: For the
Techniques: Activity Assay
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
doi: 10.3389/fcimb.2022.822599
Figure Lengend Snippet: Serial kinetics of antibody titers measured with each method: (A) PRNT ND50, (B.) GenScript cPass sVNT, (C) Roche Elecsys Anti-SARS-CoV-2, (D) Roche Elecsys Anti-SARS-CoV2 S, and (E) Abbott AdviseDx SARS-CoV2 IgG II.
Article Snippet: For the
Techniques:
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
doi: 10.3389/fcimb.2022.822599
Figure Lengend Snippet: Antibody titers by timeline.
Article Snippet: For the
Techniques:
Journal: Frontiers in Cellular and Infection Microbiology
Article Title: Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
doi: 10.3389/fcimb.2022.822599
Figure Lengend Snippet: Scatter plot and Pearson’s correlation for each method grouped with acute/convalescent phase. (A) GenScript cPass sVNT, (B) Roche Elecsys Anti-SARS-CoV-2, (C) Roche Elecsys Anti-SARS-CoV2 S, and (D) Abbott AdviseDx SARS-CoV2 IgG II were compared with PRNT, respectively. Each colored line depicts the linear regression model and the surrounding grey-colored area represents the 95% confidence interval.
Article Snippet: For the
Techniques: